NAM Statistics

Total Valuation

Namwiwat Medical Corporation PCL has a market cap or net worth of THB 3.23 billion. The enterprise value is 2.55 billion.

Market Cap	3.23B
Enterprise Value	2.55B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Namwiwat Medical Corporation PCL has 700.00 million shares outstanding. The number of shares has increased by 2,437.32% in one year.

Current Share Class	n/a
Shares Outstanding	700.00M
Shares Change (YoY)	+2,437.32%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	59.17%
Owned by Institutions (%)	1.73%
Float	93.28M

Valuation Ratios

The trailing PE ratio is 18.37 and the forward PE ratio is 14.90.

PE Ratio	18.37
Forward PE	14.90
PS Ratio	3.28
PB Ratio	1.60
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.11, with an EV/FCF ratio of -166.41.

EV / Earnings	14.61
EV / Sales	2.61
EV / EBITDA	10.11
EV / EBIT	11.57
EV / FCF	-166.41

Financial Position

The company has a current ratio of 5.09, with a Debt / Equity ratio of 0.12.

Current Ratio	5.09
Quick Ratio	3.84
Debt / Equity	0.12
Debt / EBITDA	0.95
Debt / FCF	-15.69
Interest Coverage	16.35

Financial Efficiency

Return on equity (ROE) is 11.02% and return on invested capital (ROIC) is 7.34%.

Return on Equity (ROE)	11.02%
Return on Assets (ROA)	6.69%
Return on Capital (ROIC)	7.34%
Revenue Per Employee	2.41M
Profits Per Employee	429,382
Employee Count	406
Asset Turnover	0.48
Inventory Turnover	1.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.67%
50-Day Moving Average	4.70
200-Day Moving Average	4.92
Relative Strength Index (RSI)	52.58
Average Volume (20 Days)	273,295

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Namwiwat Medical Corporation PCL had revenue of THB 977.40 million and earned 174.33 million in profits. Earnings per share was 0.25.

Revenue	977.40M
Gross Profit	456.83M
Operating Income	220.11M
Pretax Income	219.33M
Net Income	174.33M
EBITDA	249.48M
EBIT	220.11M
Earnings Per Share (EPS)	0.25

Full Income Statement

Balance Sheet

The company has 939.18 million in cash and 240.08 million in debt, giving a net cash position of 699.11 million or 1.00 per share.

Cash & Cash Equivalents	939.18M
Total Debt	240.08M
Net Cash	699.11M
Net Cash Per Share	1.00
Equity (Book Value)	2.04B
Book Value Per Share	2.89
Working Capital	1.54B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 37.13 million and capital expenditures -52.44 million, giving a free cash flow of -15.31 million.

Operating Cash Flow	37.13M
Capital Expenditures	-52.44M
Free Cash Flow	-15.31M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 46.74%, with operating and profit margins of 22.52% and 17.84%.

Gross Margin	46.74%
Operating Margin	22.52%
Pretax Margin	22.44%
Profit Margin	17.84%
EBITDA Margin	25.52%
EBIT Margin	22.52%
FCF Margin	-1.57%

Dividends & Yields

This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 1.95%.

Dividend Per Share	0.09
Dividend Yield	1.95%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	36.13%
Buyback Yield	-2,437.32%
Shareholder Yield	-2,435.37%
Earnings Yield	5.44%
FCF Yield	-0.47%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a